Hongsheng Wang

机构：Sun Yat-sen University, Shanghai Jiao Tong University, Guangdong Pharmaceutical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Shanghai Chest Hospital, Shanghai Cancer Institute, Chinese Academy of Medical Sciences Dermatology Hospital, Shanghai First People's Hospital · ORCID：0000-0003-2615-0480

发表论文 66 篇 · 总被引 2374 次 · h-index 24

代表论文

• Multi-omics analysis identifies osteosarcoma subtypes with distinct prognosis indicating stratified treatment (2022 · Nature Communications · 被引 146)
• Her4 promotes cancer metabolic reprogramming via the c-Myc-dependent signaling axis (2020 · Cancer Letters · 被引 51)
• Anlotinib Reverses Multidrug Resistance (MDR) in Osteosarcoma by Inhibiting P-Glycoprotein (PGP1) Function In Vitro and In Vivo (2022 · Frontiers in Pharmacology · 被引 24)
• NIR‐II AIEgens nanosystem for fluorescence and chemiluminescence synergistic imaging‐guided precise resection in osteosarcoma surgery (2024 · Aggregate · 被引 23)
• Pectolinarigenin acts as a potential anti-osteosarcoma agent via mediating SHP-1/JAK2/STAT3 signaling (2022 · Biomedicine & Pharmacotherapy · 被引 18)
• Revision surgeries for tumor endoprostheses around the knee joint: a mid-long-term follow-up of 20 cases (2022 · World Journal of Surgical Oncology · 被引 18)